SG11202006730SA - Botulinum neurotoxin biohybrid - Google Patents

Botulinum neurotoxin biohybrid

Info

Publication number
SG11202006730SA
SG11202006730SA SG11202006730SA SG11202006730SA SG11202006730SA SG 11202006730S A SG11202006730S A SG 11202006730SA SG 11202006730S A SG11202006730S A SG 11202006730SA SG 11202006730S A SG11202006730S A SG 11202006730SA SG 11202006730S A SG11202006730S A SG 11202006730SA
Authority
SG
Singapore
Prior art keywords
biohybrid
botulinum neurotoxin
neurotoxin
botulinum
neurotoxin biohybrid
Prior art date
Application number
SG11202006730SA
Other languages
English (en)
Inventor
Pål Stenmark
Geoffrey Masuyer
Original Assignee
Toxotech Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toxotech Ab filed Critical Toxotech Ab
Publication of SG11202006730SA publication Critical patent/SG11202006730SA/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/48Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/52Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/164Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46Hydrolases (3)
    • A61K38/48Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/4886Metalloendopeptidases (3.4.24), e.g. collagenase
    • A61K38/4893Botulinum neurotoxin (3.4.24.69)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64Proteins; Peptides; Derivatives or degradation products thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/66Enzymes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/08Anti-ageing preparations
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/33Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Clostridium (G)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K19/00Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62DNA sequences coding for fusion proteins
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y304/00Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/24Metalloendopeptidases (3.4.24)
    • C12Y304/24069Bontoxilysin (3.4.24.69), i.e. botulinum neurotoxin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/91Injection
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/55Fusion polypeptide containing a fusion with a toxin, e.g. diphteria toxin
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Birds (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Dermatology (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SG11202006730SA 2018-02-26 2019-02-21 Botulinum neurotoxin biohybrid SG11202006730SA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE1850213A SE542539C2 (en) 2018-02-26 2018-02-26 Chimeric botulinum neurotoxin heavy chain binding domain
PCT/EP2019/054310 WO2019162376A1 (en) 2018-02-26 2019-02-21 Botulinum neurotoxin biohybrid

Publications (1)

Publication Number Publication Date
SG11202006730SA true SG11202006730SA (en) 2020-08-28

Family

ID=65576340

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11202006730SA SG11202006730SA (en) 2018-02-26 2019-02-21 Botulinum neurotoxin biohybrid

Country Status (16)

Country Link
US (2) US20200407702A1 (https=)
EP (1) EP3759124A1 (https=)
JP (2) JP7458999B2 (https=)
KR (1) KR20200127175A (https=)
CN (1) CN111819189A (https=)
AU (2) AU2019223130B2 (https=)
BR (1) BR112020017323A2 (https=)
CA (1) CA3088928A1 (https=)
CL (1) CL2020002186A1 (https=)
IL (1) IL276930A (https=)
MX (1) MX2020008834A (https=)
MY (1) MY202690A (https=)
PH (1) PH12020551270A1 (https=)
SE (1) SE542539C2 (https=)
SG (1) SG11202006730SA (https=)
WO (1) WO2019162376A1 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3752128B1 (de) * 2018-02-16 2025-01-15 preclinics discovery GmbH Nukleinsäure-basiertes botulinum neurotoxin zur therapeutischen anwendung
IL272002A (en) 2020-01-13 2021-07-29 The Israel Institute Of Biological Res Iibr Methods for identifying anti clostridial neurotoxin compounds
EP4093434A4 (en) * 2020-01-21 2024-06-26 Trustees of Dartmouth College Immunologically optimized botulinum toxin light chain variants
CN111675754A (zh) * 2020-05-19 2020-09-18 四川一埃科技有限公司 一种肉毒毒素蛋白晶体结构及晶体制备方法和解析方法
CN114957482B (zh) * 2021-02-26 2024-09-24 重庆誉颜制药有限公司 一种经修饰的神经毒素的单链多肽及其用途

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102219837B (zh) * 2010-05-20 2013-10-30 中国人民解放军军事医学科学院微生物流行病研究所 重组全长a型肉毒毒素突变体疫苗
SG10201606666XA (en) * 2012-05-30 2016-09-29 Harvard College Engineered Botulinum Neurotoxin
PT3274364T (pt) * 2015-03-26 2021-11-05 Harvard College Neurotoxina botulínica manipulada
TW201718627A (zh) * 2015-06-11 2017-06-01 梅茲製藥有限兩合公司 重組梭菌神經毒素及其使用與形成方法、包括其之醫藥組合物及對應其之前驅物、編碼前驅物之核酸序列及其獲得方法與前驅物之形成方法、載體與包括核酸序列之重組宿主細胞
GB201607901D0 (en) * 2016-05-05 2016-06-22 Ipsen Biopharm Ltd Chimeric neurotoxins
US11242515B2 (en) 2016-05-16 2022-02-08 President And Fellows Of Harvard College Method for purification and activation of botulinum neurotoxin
CN109476713A (zh) 2016-06-08 2019-03-15 儿童医学中心公司 工程改造的肉毒杆菌神经毒素

Also Published As

Publication number Publication date
CA3088928A1 (en) 2019-08-29
SE542539C2 (en) 2020-06-02
RU2020131317A (ru) 2022-03-29
IL276930A (en) 2020-10-29
CL2020002186A1 (es) 2020-12-28
MY202690A (en) 2024-05-15
SE1850213A1 (en) 2019-08-27
KR20200127175A (ko) 2020-11-10
CN111819189A (zh) 2020-10-23
JP7458999B2 (ja) 2024-04-01
WO2019162376A1 (en) 2019-08-29
JP2024069606A (ja) 2024-05-21
US20200407702A1 (en) 2020-12-31
AU2019223130B2 (en) 2024-07-25
AU2024227611A1 (en) 2024-11-14
JP2021514674A (ja) 2021-06-17
BR112020017323A2 (pt) 2020-12-29
AU2019223130A1 (en) 2020-09-10
US20250034540A1 (en) 2025-01-30
MX2020008834A (es) 2021-01-08
EP3759124A1 (en) 2021-01-06
PH12020551270A1 (en) 2021-05-31

Similar Documents

Publication Publication Date Title
ZA201900341B (en) A novel botulinum neurotoxin and its derivatives
PT3274364T (pt) Neurotoxina botulínica manipulada
IL263058A (en) Engineered botulinum neurotoxins
SG11202003671VA (en) Non-neuronal snare-cleaving botulinum neurotoxins
IL276930A (en) Botulinum toxin biohybrid
DK3882540T3 (en) Køleanordning til containere
GB201607901D0 (en) Chimeric neurotoxins
IL253429B (en) A container filled with botulinum toxin
GB201621111D0 (en) Neurotoxins
DK3356391T3 (da) Fremgangsmåde til oprensning af clostridial neurotoksin
EP3615669A4 (en) BOTULINIC NEUROTOXINS PRODUCTION PROCESSES
DK3860777T3 (en) Hydraulisk drivsystem til et stanseapparat
SG11202012109UA (en) Engineered phosphopentomutase variant enzymes
HUE052935T2 (hu) Táptalajkészítmény botulinum toxin elõállítására
IL322128A (en) A preparation to modify the effect of the botulinum neurotoxin
SG11202105592XA (en) Botulinum toxin-stabilizing liquid composition
IL267954B (en) potassium channel modulators
EP3600385A4 (en) BOTULINUM NEUROTOXINS FOR THE TREATMENT OF TRAUMATIC INJURIES
HUE050244T2 (hu) Táptalajkészítmény Botulinum toxin elõállítására
GB201821052D0 (en) Foreign title
DK3660218T3 (en) Endeterminal til et autoværn
SG11202100814YA (en) Biohybrid peptidoglycan oligomers
HK40043340A (en) Botulinum neurotoxin biohybrid
EP3801170C0 (de) Wischplatte
GB201821057D0 (en) Foreign title